One of our strong areas of expertise we look forward to sharing with you. We have the capabilities to custom develop and validate GLP-compliant methods:

  • Qualitative and quantitative ELISA assays for detection of test substances or innovative therapeutic agents in formats such as direct, sandwich, bridge, competitive.
  • Flow cytometry assays for:
    • Immunophenotyping of lymphocytes and other blood cells
    • Specific cell surface or intracellular marker combinations for the diagnosis and prognosis of hematopoetic cancers
    • Detection of peripheral CECs
  • Immunohistochemical methods for the detection and quantification of protein expressions (intracellular or cell surface markers)
  • Immunoblotting, immunophenotyping and immunoprecipitation methods
  • Development, purification and characterization of antibodies
  • Detection of cytokines, chemokines, antibodies and other biomarkers with the xMAP technology on the Luminex 



These are only a few examples of what we can do. For more information, or a special request, please contact us toll free at 1-866-688-2474 or by e-mail at


< back


© 2020 CIRION BioPharma Research Inc. All rights reserved.  Legal notice  Privacy Policy